Risk of Bias and Heterogeneity-Reply

Affiliations

¹ Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

Comment

Mizuki Nishino et al. JAMA Oncol. 2017.

. 2017 Jun 1;3(6):858-859.

doi: 10.1001/jamaoncol.2017.0160.

¹ Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Comment on

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Nishino M, Giobbie-Hurder A, Hatabu H, Ramaiya NH, Hodi FS. Nishino M, et al. JAMA Oncol. 2016 Dec 1;2(12):1607-1616. doi: 10.1001/jamaoncol.2016.2453. JAMA Oncol. 2016. PMID: 27540850
Risk of Bias and Heterogeneity.
Matsumoto H, Kataoka Y. Matsumoto H, et al. JAMA Oncol. 2017 Jun 1;3(6):857-858. doi: 10.1001/jamaoncol.2017.0164. JAMA Oncol. 2017. PMID: 28334363 No abstract available.